DAVA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Endava PLC (DAVA) is not a strong buy at the moment for a beginner investor with a long-term focus. The company's financial performance is weak, with declining revenue, net income, and EPS. Analyst ratings are neutral to slightly negative, with lowered price targets. Technical indicators show no clear bullish signal, and there are no significant positive catalysts or trading trends. While options data indicates a low Open Interest Put-Call Ratio (0.14), suggesting limited bearish sentiment, the overall outlook does not justify a buy recommendation.
The MACD is positive and expanding, indicating a slight bullish momentum. RSI is neutral at 71.213, and moving averages are converging, showing no clear trend. The stock is trading near its resistance level (R1: 4.76), with limited upside potential in the short term.
NULL identified. No recent news or significant trading trends from insiders or hedge funds.
Declining financial performance, including a YoY revenue drop of -5.88%, net income down -200.80%, and EPS down -218.18%. Analyst ratings have been downgraded, with price targets reduced across the board.
In Q2 2026, Endava's revenue dropped to $184.1M (-5.88% YoY), net income fell to -$6.91M (-200.80% YoY), and EPS declined to -0.13 (-218.18% YoY). Gross margin also decreased to 20.42% (-11.29% YoY).
Analysts have lowered price targets consistently over the past months. TD Cowen reduced the target to $6 from $6.50, maintaining a Hold rating. JPMorgan and Guggenheim also lowered targets, with Guggenheim maintaining a Buy rating but noting undemanding valuation and healthy free cash flow.
